Clinical Trial Update: Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hepatic arterial infusion of oxaliplatin, fluorouracil/leucovorin to sorafenib in advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Oxaliplatin, fluorouracil/leucovorin via hepatic arterial infusion
• Sorafenib (Sorafenib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Cancer, Hepatic Carcinoma | Phase 3 | Status: COMPLETED